Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Preclinical crawled time : 12:00 save search
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.1948 -15.0% 200K
|
Manufacturing
| Email alert
Add to watchlist
rose publication tumor preclinical for
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -3.83%
H: 0.0%
C: 0.0%
breast cancer preclinical for
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
CADL | $5.55 7.35% 6.85% 580K
|
|
| O: 3.99%
H: 4.32%
C: -18.56%
candidate tumors preclinical immunotherapy for therapeutics
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
TPST | $3.25 4.84% 4.62% 390K
|
Manufacturing
|
| O: 2.83%
H: 4.5%
C: -3.25%
tpst-1120 preclinical for meeting
ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
ORIC | $8.74 -4.9% -5.51% 320K
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: -2.71%
association cancer pharmaceuticals research preclinical for meeting
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CCCC | $6.88 2.38% 2.33% 750K
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 association approved cancer care research preclinical for meeting therapeutics
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
Published: 2024-04-05 (Crawled : 12:00) - globenewswire.com
LIPO | $0.7179 -0.89% 20K
|
|
| O: -0.6%
H: 6.74%
C: 6.74%
candidate asco pharmaceuticals preclinical for
Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: -2.03%
H: 13.79%
C: 12.41%
preclinical potential platform
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
PPBT | $0.46 1.1% 1.09% 100K
|
Manufacturing
|
| O: 4.06%
H: 0.0%
C: -6.04%
biotech preclinical purple technology platform
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: 3.78%
H: 5.27%
C: -1.04%
infectimune patent biotech publication research preclinical grant
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
FBIO | $1.76 0.57% 0.57% 150K
|
Health Technology
|
| O: -0.48%
H: 2.87%
C: -4.31%
ATXI | $0.1322 1.69% 1.66% 1.6M
|
Health Technology
|
| O: -7.03%
H: 0.0%
C: -9.24%
baer-101 preclinical meeting therapeutics
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
Published: 2024-03-08 (Crawled : 12:00) - globenewswire.com
ATHA | $2.08 -2.35% -2.4% 130K
|
Health Technology
|
| O: 0.0%
H: 1.45%
C: -13.73%
fosgonimeton pharma conference alzheimer’s international preclinical parkinson’s potential
BeiGene to Present Clinical and Preclinical Data from Broad Portfolio and Pipeline at AACR Annual Meeting 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
BGNE | $131.15 1.26% 1.24% 150K
|
Health Technology
|
| O: 0.54%
H: 0.46%
C: -1.09%
pipeline preclinical meeting
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
Published: 2024-03-05 (Crawled : 12:00) - globenewswire.com
MNPR | $0.6401 -6.6% 28K
|
Health Technology
|
| O: 5.04%
H: 15.38%
C: 1.92%
mnpr-101 positive preclinical program
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
ALLK | $1.05 -1.87% -1.9% 280K
|
Health Technology
|
| O: 2.21%
H: 10.07%
C: 5.04%
ak006 cell preclinical
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
MNPR | $0.6401 -6.6% 28K
|
Health Technology
|
| O: 36.88%
H: 75.6%
C: 43.55%
mnpr-101 preclinical program advanced
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
Published: 2024-02-20 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 1.72%
H: 1.82%
C: -1.43%
SGMO | News | $0.5151 0.7% 0.7% 1.3M
|
Health Technology
|
| O: -1.45%
H: 0.74%
C: -13.24%
NBIX | News M | $133.5 1.14% 1.12% 570K
|
Health Technology
|
| O: 0.63%
H: 0.8%
C: -0.37%
disease alzheimer’s research preclinical tau program therapeutics therapy
Regeneron Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio Platforms and Preclinical and Clinical Programs
Published: 2024-01-30 (Crawled : 12:00) - globenewswire.com
TSVT | $4.67 3.32% 3.21% 410K
|
|
| O: 11.17%
H: 12.63%
C: 3.35%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
REGN | News | $899.71 0.32% 0.32% 340K
|
Health Technology
|
| O: 0.02%
H: 0.44%
C: 0.39%
cell acquisition preclinical
Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data
Published: 2024-01-16 (Crawled : 12:00) - globenewswire.com
CLRB | $3.18 4.95% 4.72% 870K
|
Health Technology
|
| O: -0.57%
H: 8.88%
C: 6.02%
tumors pipeline preclinical therapy
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
Published: 2024-01-02 (Crawled : 12:00) - prnewswire.com
CLGN | $5.19 -0.19% -0.19% 4.3K
|
Health Technology
|
| O: -2.82%
H: 6.6%
C: -2.58%
biotechnologies breast preclinical trial
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.